Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ohyabu

Showing results (81-90 of 95) with videos related to

Pageof 10
Sort By:
Chemistry (Weinheim an Der Bergstrasse, Germany)|January 26, 2011
An efficient approach for the characterization of mucin-type glycopeptides: the effect of O-glycosylation on the conformation of synthetic mucin peptidesRyo Hashimoto, Naoki Fujitani, Yasuhiro Takegawa, et al.
Physical Review Letters|January 22, 2002
Observation of plasma flow at the magnetic island in the large helical deviceK Ida, N Ohyabu, T Morisaki, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|March 29, 2008
The membrane proteinase 3 expression on neutrophils was downregulated after treatment with infliximab in patients with rheumatoid arthritisTakeshi Matsumoto, Toshihiro Kaneko, Masashi Seto, et al.
Biochemistry|October 27, 2009
Functional neoglycopeptides: synthesis and characterization of a new class of MUC1 glycoprotein models having core 2-based O-glycan and complex-type N-glycan chainsTakahiko Matsushita, Reiko Sadamoto, Naoki Ohyabu, et al.
Bioorganic & Medicinal Chemistry|August 21, 2013
Design, synthesis, and structure-activity relationships of dihydrofuran-2-one and dihydropyrrol-2-one derivatives as novel benzoxazin-3-one-based mineralocorticoid receptor antagonistsTomoaki Hasui, Taiichi Ohra, Norio Ohyabu, et al.
ACS Medicinal Chemistry Letters|March 17, 2022
Discovery of TAK-925 as a Potent, Selective, and Brain-Penetrant Orexin 2 Receptor AgonistTatsuhiko Fujimoto, Kentaro Rikimaru, Koichiro Fukuda, et al.
Bioscience Reports|July 16, 2008
Discovery of novel non-peptide thrombopoietin mimetic compounds that induce megakaryocytopoiesisNoriko Yamane, Koji Takahashi, Yoshikazu Tanaka, et al.
Journal of Medicinal Chemistry|November 15, 2011
Identification of benzoxazin-3-one derivatives as novel, potent, and selective nonsteroidal mineralocorticoid receptor antagonistsTomoaki Hasui, Nobuyuki Matsunaga, Taiichi Ora, et al.
Bioorganic & Medicinal Chemistry|September 5, 2014
Discovery of 6-[5-(4-fluorophenyl)-3-methyl-pyrazol-4-yl]-benzoxazin-3-one derivatives as novel selective nonsteroidal mineralocorticoid receptor antagonistsTomoaki Hasui, Norio Ohyabu, Taiichi Ohra, et al.
Journal of Medicinal Chemistry|October 21, 2025
Discovery of Pyrazole-Based Positron Emission Tomography Agent that Maps Histone Deacetylase 6 (HDAC6) in the Nonhuman Primate BrainTomoteru Yamasaki, Norio Ohyabu, Takeshi Wakabayashi, et al.
Pageof 10

Showing results (81-90 of 95) with videos related to

Sort By:
Pageof 10
Chemistry (Weinheim an Der Bergstrasse, Germany)|January 26, 2011
An efficient approach for the characterization of mucin-type glycopeptides: the effect of O-glycosylation on the conformation of synthetic mucin peptidesRyo Hashimoto, Naoki Fujitani, Yasuhiro Takegawa, et al.
Physical Review Letters|January 22, 2002
Observation of plasma flow at the magnetic island in the large helical deviceK Ida, N Ohyabu, T Morisaki, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|March 29, 2008
The membrane proteinase 3 expression on neutrophils was downregulated after treatment with infliximab in patients with rheumatoid arthritisTakeshi Matsumoto, Toshihiro Kaneko, Masashi Seto, et al.
Biochemistry|October 27, 2009
Functional neoglycopeptides: synthesis and characterization of a new class of MUC1 glycoprotein models having core 2-based O-glycan and complex-type N-glycan chainsTakahiko Matsushita, Reiko Sadamoto, Naoki Ohyabu, et al.
Bioorganic & Medicinal Chemistry|August 21, 2013
Design, synthesis, and structure-activity relationships of dihydrofuran-2-one and dihydropyrrol-2-one derivatives as novel benzoxazin-3-one-based mineralocorticoid receptor antagonistsTomoaki Hasui, Taiichi Ohra, Norio Ohyabu, et al.
ACS Medicinal Chemistry Letters|March 17, 2022
Discovery of TAK-925 as a Potent, Selective, and Brain-Penetrant Orexin 2 Receptor AgonistTatsuhiko Fujimoto, Kentaro Rikimaru, Koichiro Fukuda, et al.
Bioscience Reports|July 16, 2008
Discovery of novel non-peptide thrombopoietin mimetic compounds that induce megakaryocytopoiesisNoriko Yamane, Koji Takahashi, Yoshikazu Tanaka, et al.
Journal of Medicinal Chemistry|November 15, 2011
Identification of benzoxazin-3-one derivatives as novel, potent, and selective nonsteroidal mineralocorticoid receptor antagonistsTomoaki Hasui, Nobuyuki Matsunaga, Taiichi Ora, et al.
Bioorganic & Medicinal Chemistry|September 5, 2014
Discovery of 6-[5-(4-fluorophenyl)-3-methyl-pyrazol-4-yl]-benzoxazin-3-one derivatives as novel selective nonsteroidal mineralocorticoid receptor antagonistsTomoaki Hasui, Norio Ohyabu, Taiichi Ohra, et al.
Journal of Medicinal Chemistry|October 21, 2025
Discovery of Pyrazole-Based Positron Emission Tomography Agent that Maps Histone Deacetylase 6 (HDAC6) in the Nonhuman Primate BrainTomoteru Yamasaki, Norio Ohyabu, Takeshi Wakabayashi, et al.
Pageof 10